• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bionoid Pharma Inc (OP:BINP)

    0.0240 +0.0069 (+40.35%)
    Streaming Delayed Price Updated: 10:39 AM EDT, Oct 6, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Bionoid Pharma Inc

    < Previous 1 2 Next >
    AI Maverick Intel Inc. (BINP) Poised to Help Businesses Optimize the Customer Acquisition Experience Using AI
    Via Investor Brand Network
    Topics Artificial Intelligence
    AINewsBreaks – AI Maverick Intel Inc. (BINP) Moves Beyond Lead Gen with Consultative Sales Platform
    Via Investor Brand Network
    Topics Artificial Intelligence
    AI Maverick Intel Inc. (BINP) Transforms Customer Acquisition with AI-Driven Automation
    Via Investor Brand Network
    Topics Artificial Intelligence
    AINewsBreaks – Prospecting Reimagined: AI Maverick Intel Inc. (BINP) Automates the Human Touch
    Via Investor Brand Network
    Topics Artificial Intelligence
    Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval
    Via ACCESS Newswire
    AI Maverick Intel Inc. (BINP) Unveils Revolutionary Prospecting Platform that Moves Beyond Simple Lead Generation
    Via Investor Brand Network
    Topics Artificial Intelligence
    AI Maverick Intel Inc. (BINP): AI-Powered Prospecting Steps Into the Sales Rep’s Shoes
    Via Investor Brand Network
    Topics Artificial Intelligence
    InvestorNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Launches Next-Generation AI Prospecting Platform for Transactional and Consultative Sales
    Via Investor Brand Network
    Topics Artificial Intelligence
    AI Maverick Intel Provides Corporate Update
    Via ACCESS Newswire
    TechMediaBreaks – Why AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
    Via Investor Brand Network
    Topics Artificial Intelligence
    AI Maverick Intel Inc. (BINP): The AI Platform That Might Just Replace Your SDR Team
    Via Investor Brand Network
    Topics Artificial Intelligence
    InvestorNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Engages IBN to Lead Corporate Communications Strategy
    Via Investor Brand Network
    Topics Artificial Intelligence
    AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
    Via Investor Brand Network
    Topics Artificial Intelligence
    IBN Initiates Coverage of AI Maverick Intel Inc.
    Via ACCESS Newswire
    AINewsBreaks – AI Maverick Intel Inc. (OTC PINK: BINP) Launches Full-Scale AI Prospecting Engine for Automated Sales Engagement
    Via Investor Brand Network
    Topics Artificial Intelligence
    InvestorNewsBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Launches Full-Scale AI Prospecting Engine for Automated Sales Engagement
    Via Investor Brand Network
    Topics Artificial Intelligence
    AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required
    Via ACCESS Newswire
    AI Maverick Launches Enhanced Prospecting Platform to Deliver Human-Like Outreach—No SDR Team Required
    From AI Maverick Intel, Inc.
    Via GlobeNewswire
    TechMediaBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement
    Via Investor Brand Network
    Topics Artificial Intelligence
    Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
    Via ACCESS Newswire
    Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
    Via ACCESS Newswire
    Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
    Via ACCESS Newswire
    Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
    Via ACCESS Newswire
    Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm
    Via ACCESS Newswire
    Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
    Via ACCESSWIRE
    Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
    Via ACCESSWIRE
    Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
    Via ACCESSWIRE
    AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
    Via ACCESSWIRE
    The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time
    Via ACCESSWIRE
    Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion
    Via ACCESSWIRE
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.